OTTAWA, Dec 2 (Reuters) - Canadian health authorities should soon complete their regulatory review of Pfizer Inc (NYSE:PFE)'s PFE.N coronavirus vaccine candidate, Health Minister Patty Hajdu tweeted on Wednesday.
Hajdu made her remarks shortly after Britain approved the candidate, a development she said was encouraging. Pfizer developed the vaccine with its German partner BioNTech SE 22UAy.DE .